Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Cancer Chemotherapy and Pharmacology|May 22, 2010
Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN)Eric H Kraut, Christopher Rhoades, Yilong Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|December 30, 2008
Curcumin is a potent DNA hypomethylation agentZhongfa Liu, Zhiliang Xie, William Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
The combination of the proteasome inhibitor bortezomib and the bcl-2 antisense molecule oblimersen sensitizes human B-cell lymphomas to cyclophosphamideOwen A O'Connor, Emily A Smith, Lorraine E Toner, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 29, 2007
Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cellsShujun Liu, Rebecca B Klisovic, Tamara Vukosavljevic, et al.
Molecular Pharmaceutics|May 12, 2012
Synthetic microRNA cassette dosing: pharmacokinetics, tissue distribution and bioactivityHongyan Wang, Ming Chiu, Zhiliang Xie, et al.
Carcinogenesis|March 29, 2003
Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2Manuela Gago-Dominguez, Douglas A Bell, Mary A Watson, et al.
Blood|December 14, 2011
Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabineDonald Lavelle, Kestis Vaitkus, Yonghua Ling, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 12, 2011
Effects of human oral mucosal tissue, saliva, and oral microflora on intraoral metabolism and bioactivation of black raspberry anthocyaninsSusan R Mallery, Deric E Budendorf, Matthew P Larsen, et al.
Pageof 10